nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
|
Ford, Ian |
|
2002 |
3 |
1 |
|
artikel |
2 |
A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data
|
Lear, Scott A |
|
2002 |
3 |
1 |
|
artikel |
3 |
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy
|
Bryson, Chris L |
|
2002 |
3 |
1 |
|
artikel |
4 |
Clinical significance of cardiovascular dysmetabolic syndrome
|
Deedwania, Prakash C |
|
2002 |
3 |
1 |
|
artikel |
5 |
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors
|
Chiabrando, Chiara |
|
2002 |
3 |
1 |
|
artikel |
6 |
Pooling, meta-analysis, and the evaluation of drug safety
|
Lièvre, Michel |
|
2002 |
3 |
1 |
|
artikel |
7 |
Problems in dealing with missing data and informative censoring in clinical trials
|
Shih, Weichung Joseph |
|
2002 |
3 |
1 |
|
artikel |
8 |
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
|
Aronow, Herbert D |
|
2002 |
3 |
1 |
|
artikel |
9 |
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
|
Piller, Linda B |
|
2002 |
3 |
1 |
|
artikel |
10 |
Weight-modification trials in older adults: what should the outcome measure be?
|
Diehr, Paula |
|
2002 |
3 |
1 |
|
artikel |